Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Univest Financial | UVSP | Jan 17, 2025 | 29.69 | +0.92 |
Unum Group | UNM | Jan 17, 2025 | 74.98 | +0.92 |
Unusual Machines | UMAC | Jan 17, 2025 | 12.95 | -3.86 |
UP Fintech A ADR | TIGR | Jan 17, 2025 | 6.77 | +8.49 |
Upbound | UPBD | Jan 17, 2025 | 29.54 | +0.14 |
Upexi | UPXI | Jan 17, 2025 | 3.46 | -0.57 |
Upland Software | UPLD | Jan 17, 2025 | 3.84 | -3.76 |
Upstart Holdings | UPST | Jan 17, 2025 | 62.96 | -2.39 |
Upstream Bio | UPB | Jan 17, 2025 | 11.00 | 0.00 |
Upwork | UPWK | Jan 17, 2025 | 16.89 | +3.18 |
Ur-Energy | URG | Jan 17, 2025 | 1.11 | 0.00 |
Uranium Energy | UEC | Jan 17, 2025 | 7.08 | +3.36 |
Uranium Royalty | UROY | Jan 17, 2025 | 2.32 | +3.57 |
Uranium+Nuclear Energy ETF Market Vectors | NLR | Jan 17, 2025 | 87.26 | +1.54 |
Urban Edge Properties | UE | Jan 17, 2025 | 20.19 | -0.64 |
Urban One A | UONE | Jan 17, 2025 | 1.46 | -3.31 |
Urban One D | UONEK | Jan 17, 2025 | 0.93 | +8.70 |
Urban Outfitters | URBN | Jan 17, 2025 | 55.01 | +3.38 |
urban-gro | UGRO | Jan 17, 2025 | 0.94 | -3.10 |
Urgently | ULY | Jan 17, 2025 | 0.53 | +6.00 |
UroGen Pharma | URGN | Jan 17, 2025 | 10.27 | -2.38 |
US 12 Month Oil | USL | Jan 17, 2025 | 39.85 | -0.29 |
US Anti-Beta Fund Market Neutral Quantshares | BTAL | Jan 17, 2025 | 17.93 | -0.39 |
US Bancorp | USB-R | Jan 17, 2025 | 17.42 | -0.57 |
US Brent Oil | BNO | Jan 17, 2025 | 32.65 | -0.73 |
US Commodity Index | USCI | Jan 17, 2025 | 69.17 | +0.07 |
US Copper | CPER | Jan 17, 2025 | 27.25 | -1.80 |
US Foods | USFD | Jan 17, 2025 | 68.31 | +0.34 |
US Gasoline | UGA | Jan 17, 2025 | 66.14 | -0.59 |
US Ipo Index First Trust | FPX | Jan 17, 2025 | 127.56 | +1.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.